التداخل بين أرغاتروبان وتيروفيبان

Concomitant use of argatroban with antiplatelet agents, thrombolytics, and other anticoagulants may increase the risk of bleeding.

Concomitant use of fibrinolytics, anticoagulants and antiplatelet drugs increases the risk of bleeding.

Coadministration of fibrinolytics, anticoagulants and antiplatelet agents, increases the risk of bleeding.